These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3699321)

  • 1. Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration.
    Somani SM; Khalique A
    Fundam Appl Toxicol; 1986 Feb; 6(2):327-34. PubMed ID: 3699321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
    Somani SM
    Biopharm Drug Dispos; 1989; 10(2):187-203. PubMed ID: 2706318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic and muscle clearance of physostigmine in the rat.
    Unni LK; Somani SM
    Drug Metab Dispos; 1986; 14(2):183-9. PubMed ID: 2870892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
    Somani SM; Khalique A
    Drug Metab Dispos; 1987; 15(5):627-33. PubMed ID: 2891478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.
    Giacobini E; Somani S; McIlhany M; Downen M; Hallak M
    Neuropharmacology; 1987 Jul; 26(7B):831-6. PubMed ID: 3658115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary pharmacokinetics of physostigmine in the rat.
    Somani SM; Boyer A
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):343-7. PubMed ID: 3830722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of biliary excretion of physostigmine in rat.
    Boyer AW; Somani SM
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):180-92. PubMed ID: 4096611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of physostigmine and metabolites in brain subcellular fractions of the rat.
    King BF; Somani SM
    Life Sci; 1987 Oct; 41(17):2007-15. PubMed ID: 3669907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of two inhibitors on brain cholinesterase.
    Hallak M; Giacobini E
    Neuropharmacology; 1987 Jun; 26(6):521-30. PubMed ID: 3601008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
    De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
    Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo dose response relationship between physostigmine and cholinesterase activity in RBC and tissues of rats.
    Somani SM; Dube SN
    Life Sci; 1989; 44(25):1907-15. PubMed ID: 2739507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physostigmine--an overview as pretreatment drug for organophosphate intoxication.
    Somani SM; Dube SN
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):367-87. PubMed ID: 2676871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of concurrent exercise and physostigmine on lactate and pyruvate in plasma, muscle, and brain tissue of rats.
    Buckenmeyer PJ; Babu SR; Knowlton RG; Somani SM
    Pharmacol Biochem Behav; 1994 Apr; 47(4):779-88. PubMed ID: 8029245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.
    Hallak M; Giacobini E
    Neurochem Res; 1986 Jul; 11(7):1037-48. PubMed ID: 3748273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of physostigmine in plasma and cerebrospinal fluid by liquid chromatography with electrochemical detection.
    Unni LK; Hannant ME; Becker RE; Giacobini E
    Clin Chem; 1989 Feb; 35(2):292-5. PubMed ID: 2914376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vivo assessment of a transdermal system for physostigmine.
    Benech H; Vincenti M; Fouchart F; Pruvost A; Vienet R; Istin M; Grognet JM
    Methods Find Exp Clin Pharmacol; 1998; 20(6):489-98. PubMed ID: 9789873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of physostigmine intramuscularly administered to guinea pigs.
    Lukey BJ; Parrish JH; Marlow DD; Clark CR; Sidell FR
    J Pharm Sci; 1990 Sep; 79(9):796-8. PubMed ID: 2273462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physostigmine on plasma lactate and pyruvate in untrained/trained rats.
    Babu SR; Buckenmeyer P; Knowlton RG; Somani SM
    Pharmacol Biochem Behav; 1992 May; 42(1):67-73. PubMed ID: 1528949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of heptastigmine in rats.
    Segre G; Cerretani D; Baldi A; Urso R
    Pharmacol Res; 1992; 25(2):139-46. PubMed ID: 1635892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of physostigmine on acetylcholinesterase activity of CSF plasma and brain. A comparison of intravenous and intraventricular administration in beagle dogs.
    Mattio T; McIlhany M; Giacobini E; Hallak M
    Neuropharmacology; 1986 Oct; 25(10):1167-77. PubMed ID: 3785584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.